Schooley, Robert T.
Strathdee, Steffanie
Article History
First Online: 26 February 2020
Competing interests
: R. T. S. serves as a consultant to CytoDyn and has stock options in CytoDyn and Antiva Biosciences. He is a member of the Gilead Sciences Scientific Advisory Board and previously served as an uncompensated member of the AmpliPhi Scientific Advisory Board. S. S. holds stock in Adaptive Phage Therapeutics and is an uncompensated scientific advisor to NextBiotics.